Global Alcoholic Hepatitis Treatment Market Size, Status and Forecast 2019-2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Alcoholic Hepatitis Treatment Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Corticosteroids
- 1.4.3 Xanthine derivatives
- 1.4.4 Other
- 1.5 Market by Application
- 1.5.1 Global Alcoholic Hepatitis Treatment Market Share by Application (2019-2025)
- 1.5.2 Hospital
- 1.5.3 Clinic
- 1.5.4 Private Treatment Center
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Alcoholic Hepatitis Treatment Market Size
- 2.2 Alcoholic Hepatitis Treatment Growth Trends by Regions
- 2.2.1 Alcoholic Hepatitis Treatment Market Size by Regions (2019-2025)
- 2.2.2 Alcoholic Hepatitis Treatment Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
- 3.1 Alcoholic Hepatitis Treatment Market Size by by Players
- 3.1.1 Global Alcoholic Hepatitis Treatment Revenue by by Players (2014-2019)
- 3.1.2 Global Alcoholic Hepatitis Treatment Revenue Market Share by by Players (2014-2019)
- 3.1.3 Global Alcoholic Hepatitis Treatment Market Concentration Ratio (CR5 and HHI)
- 3.2 Alcoholic Hepatitis Treatment Key Players Head office and Area Served
- 3.3 Key Players Alcoholic Hepatitis Treatment Product/Solution/Service
- 3.4 Date of Enter into Alcoholic Hepatitis Treatment Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Alcoholic Hepatitis Treatment Market Size by Type (2014-2019)
- 4.2 Global Alcoholic Hepatitis Treatment Market Size by Application (2014-2019)
5 North America
- 5.1 North America Alcoholic Hepatitis Treatment Market Size (2014-2019)
- 5.2 Alcoholic Hepatitis Treatment Key Players in North America
- 5.3 North America Alcoholic Hepatitis Treatment Market Size by Type
- 5.4 North America Alcoholic Hepatitis Treatment Market Size by Application
6 Europe
- 6.1 Europe Alcoholic Hepatitis Treatment Market Size (2014-2019)
- 6.2 Alcoholic Hepatitis Treatment Key Players in Europe
- 6.3 Europe Alcoholic Hepatitis Treatment Market Size by Type
- 6.4 Europe Alcoholic Hepatitis Treatment Market Size by Application
7 China
- 7.1 China Alcoholic Hepatitis Treatment Market Size (2014-2019)
- 7.2 Alcoholic Hepatitis Treatment Key Players in China
- 7.3 China Alcoholic Hepatitis Treatment Market Size by Type
- 7.4 China Alcoholic Hepatitis Treatment Market Size by Application
8 Japan
- 8.1 Japan Alcoholic Hepatitis Treatment Market Size (2014-2019)
- 8.2 Alcoholic Hepatitis Treatment Key Players in Japan
- 8.3 Japan Alcoholic Hepatitis Treatment Market Size by Type
- 8.4 Japan Alcoholic Hepatitis Treatment Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Alcoholic Hepatitis Treatment Market Size (2014-2019)
- 9.2 Alcoholic Hepatitis Treatment Key Players in Southeast Asia
- 9.3 Southeast Asia Alcoholic Hepatitis Treatment Market Size by Type
- 9.4 Southeast Asia Alcoholic Hepatitis Treatment Market Size by Application
10 India
- 10.1 India Alcoholic Hepatitis Treatment Market Size (2014-2019)
- 10.2 Alcoholic Hepatitis Treatment Key Players in India
- 10.3 India Alcoholic Hepatitis Treatment Market Size by Type
- 10.4 India Alcoholic Hepatitis Treatment Market Size by Application
11 Central & South America
- 11.1 Central & South America Alcoholic Hepatitis Treatment Market Size (2014-2019)
- 11.2 Alcoholic Hepatitis Treatment Key Players in Central & South America
- 11.3 Central & South America Alcoholic Hepatitis Treatment Market Size by Type
- 11.4 Central & South America Alcoholic Hepatitis Treatment Market Size by Application
12 International Players Profiles
- 12.1 Apotex Inc.
- 12.1.1 Apotex Inc. Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Alcoholic Hepatitis Treatment Introduction
- 12.1.4 Apotex Inc. Revenue in Alcoholic Hepatitis Treatment Business (2014-2019))
- 12.1.5 Apotex Inc. Recent Development
- 12.2 Gilead Sciences Inc.
- 12.2.1 Gilead Sciences Inc. Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Alcoholic Hepatitis Treatment Introduction
- 12.2.4 Gilead Sciences Inc. Revenue in Alcoholic Hepatitis Treatment Business (2014-2019)
- 12.2.5 Gilead Sciences Inc. Recent Development
- 12.3 Johnson & Johnson Services Inc.
- 12.3.1 Johnson & Johnson Services Inc. Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Alcoholic Hepatitis Treatment Introduction
- 12.3.4 Johnson & Johnson Services Inc. Revenue in Alcoholic Hepatitis Treatment Business (2014-2019)
- 12.3.5 Johnson & Johnson Services Inc. Recent Development
- 12.4 Novartis AG
- 12.4.1 Novartis AG Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Alcoholic Hepatitis Treatment Introduction
- 12.4.4 Novartis AG Revenue in Alcoholic Hepatitis Treatment Business (2014-2019)
- 12.4.5 Novartis AG Recent Development
- 12.5 Teva Pharmaceutical Industries Ltd.
- 12.5.1 Teva Pharmaceutical Industries Ltd. Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Alcoholic Hepatitis Treatment Introduction
- 12.5.4 Teva Pharmaceutical Industries Ltd. Revenue in Alcoholic Hepatitis Treatment Business (2014-2019)
- 12.5.5 Teva Pharmaceutical Industries Ltd. Recent Development
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Product (2019-2025)
- 13.2 Market Size Forecast by Application (2019-2025)
- 13.3 Market Size Forecast by Regions
- 13.4 North America
- 13.5 Europe
- 13.6 China
- 13.7 Japan
- 13.8 Southeast Asia
- 13.9 India
- 13.10 Central & South America
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 15.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Alcoholic hepatitis is hepatitis (inflammation of the liver) due to excessive intake of alcohol. It is usually found in association with fatty liver, an early stage of alcoholic liver disease, and may contribute to the progression of fibrosis, leading to cirrhosis.
The increasing consumption of alcohol worldwide has contributed to the growth of the market. Heavy alcohol consumption causes alcoholic hepatitis, which leads to hepatic encephalopathy. These health conditions have led to high mortality rates. As a result, there is a significant need to treat alcoholic hepatitis. Vendors are using this opportunity to release many treatment options into the market. Many off-label therapies and corticosteroids are available in the market. Off-label therapies are used to treat inflammation in alcoholic hepatitis and corticosteroids are used as first-line treatment. The demand for these drugs will increase because of the lack of curative therapies available in the market.
In 2018, the global Alcoholic Hepatitis Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Alcoholic Hepatitis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Alcoholic Hepatitis Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Apotex Inc.
Gilead Sciences Inc.
Johnson & Johnson Services Inc.
Novartis AG
Teva Pharmaceutical Industries Ltd.
...
Market segment by Type, the product can be split into
Corticosteroids
Xanthine derivatives
Other
Market segment by Application, split into
Hospital
Clinic
Private Treatment Center
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Alcoholic Hepatitis Treatment status, future forecast, growth opportunity, key market and key players.
To present the Alcoholic Hepatitis Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Alcoholic Hepatitis Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.